183 related articles for article (PubMed ID: 34194826)
1. Lipid Accumulation Product Is More Related to Insulin Resistance than the Visceral Adiposity Index in the Maracaibo City Population, Venezuela.
Bermúdez V; Salazar J; Fuenmayor J; Nava M; Ortega Á; Duran P; Rojas M; Añez R; Rivas-Montenegro A; Angarita L; Chacín M; Cano C; Velasco M; Rojas J
J Obes; 2021; 2021():5514901. PubMed ID: 34194826
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei, China.
Huang R; Cheng Z; Jin X; Yu X; Yu J; Guo Y; Zong L; Sheng J; Liu X; Wang S
Ann Med; 2022 Dec; 54(1):622-632. PubMed ID: 35175162
[TBL] [Abstract][Full Text] [Related]
3. Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?
Kavaric N; Klisic A; Ninic A
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28632304
[TBL] [Abstract][Full Text] [Related]
4. The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome.
Anik Ilhan G; Yildizhan B; Pekin T
Gynecol Endocrinol; 2019 Mar; 35(3):233-236. PubMed ID: 30303693
[TBL] [Abstract][Full Text] [Related]
5. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
[TBL] [Abstract][Full Text] [Related]
6. Lipid accumulation product and visceral adiposity index: two indices to predict metabolic syndrome and insulin resistance in chronic kidney disease patients.
Fahmy AM; El Shall N; Kabbash I; El Ahwal L; Selim A
Endocr Regul; 2023 Jan; 57(1):99-105. PubMed ID: 37183690
[No Abstract] [Full Text] [Related]
7. Association of lipid accumulation product and visceral adiposity index with the risk of hypertension among oil workers in Xinjiang, China.
Muheiyati G; Mei Y; Tao N
PeerJ; 2023; 11():e15273. PubMed ID: 37214102
[TBL] [Abstract][Full Text] [Related]
8. The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome.
Wang H; Cao H; Cao J; Zhang L
Biomed Res Int; 2023; 2023():1508675. PubMed ID: 36814799
[TBL] [Abstract][Full Text] [Related]
9. Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study.
Ramezani Tehrani F; Minooee S; Azizi F
Eur J Endocrinol; 2014 Aug; 171(2):199-207. PubMed ID: 24816947
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance.
Du T; Yuan G; Zhang M; Zhou X; Sun X; Yu X
Cardiovasc Diabetol; 2014 Oct; 13():146. PubMed ID: 25326814
[TBL] [Abstract][Full Text] [Related]
11. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype.
Du T; Yu X; Zhang J; Sun X
Acta Diabetol; 2015 Oct; 52(5):855-63. PubMed ID: 25690647
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of visceral adiposity indices and lipid accumulation products in the identification of adults at high cardiovascular risk.
Milla AMG; Chagas EBF; Miola VFB; Zanuso BO; Guiguer EL; Araújo AC; Tofano RJ; Quesada KR; Laurindo LF; Barbalho SM
Clin Investig Arterioscler; 2023; 35(5):236-242. PubMed ID: 37121826
[TBL] [Abstract][Full Text] [Related]
13. Utility of Visceral Adiposity Index and Lipid Accumulation Products to Define Metabolically-Unhealthy Polycystic Ovary Syndrome in Asian Indian Women - A Cross Sectional Study.
Shreenidhi RA; Mahey R; Rajput M; Cheluvaraju R; Upadhyay AD; Sharma JB; Kachhawa G; Bhatla N
J Hum Reprod Sci; 2024; 17(1):50-57. PubMed ID: 38665608
[TBL] [Abstract][Full Text] [Related]
14. Association of adiposity indicators with cardiometabolic multimorbidity risk in hypertensive patients: a large cross-sectional study.
Dong T; Lin W; Zhou Q; Yang Y; Liu X; Chen J; Liu H; Zhang C
Front Endocrinol (Lausanne); 2024; 15():1302296. PubMed ID: 38577567
[TBL] [Abstract][Full Text] [Related]
15. Association between obstructive sleep apnea and visceral adiposity index and lipid accumulation product: NHANES 2015-2018.
Zhou T; Chen S; Mao J; Zhu P; Yu X; Lin R
Lipids Health Dis; 2024 Apr; 23(1):100. PubMed ID: 38600516
[TBL] [Abstract][Full Text] [Related]
16. Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes.
Ahn N; Baumeister SE; Amann U; Rathmann W; Peters A; Huth C; Thorand B; Meisinger C
Sci Rep; 2019 Jul; 9(1):9693. PubMed ID: 31273286
[TBL] [Abstract][Full Text] [Related]
17. Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance.
Mazidi M; Kengne AP; Katsiki N; Mikhailidis DP; Banach M
J Diabetes Complications; 2018 Mar; 32(3):266-270. PubMed ID: 29395839
[TBL] [Abstract][Full Text] [Related]
18. The role of the visceral adiposity index in the assessment of metabolic syndrome of polycystic ovary syndrome patients: a new anthropometric index.
Rocha ALL; Baêta T; Nazareth IR; Costa JM; Caporalli JD; Oliveira MA; Couto MG; Azevedo RC; Comim FV; Oliveira FR; Reis FM; Cândido AL
Arch Gynecol Obstet; 2024 Apr; 309(4):1643-1649. PubMed ID: 38321350
[TBL] [Abstract][Full Text] [Related]
19. Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease.
Colantoni A; Bucci T; Cocomello N; Angelico F; Ettorre E; Pastori D; Lip GYH; Del Ben M; Baratta F
Cardiovasc Diabetol; 2024 May; 23(1):175. PubMed ID: 38769519
[TBL] [Abstract][Full Text] [Related]
20. Comparison of seven surrogate insulin resistance indexes for prediction of incident coronary heart disease risk: a 10-year prospective cohort study.
Liu L; Peng J; Wang N; Wu Z; Zhang Y; Cui H; Zang D; Lu F; Ma X; Yang J
Front Endocrinol (Lausanne); 2024; 15():1290226. PubMed ID: 38323107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
